Affiliation:
1. Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy
Abstract
Abstract
Context
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 18 million people worldwide and the pandemic is still spreading. After the first case we reported, we observed 4 additional cases of subacute thyroiditis (SAT) related to SARS-CoV-2 infection.
Objectives
The objective of this work is to describe additional cases of SAT associated with SARS-CoV-2 infection to alert physicians that SAT may be a manifestation of SARS-CoV-2 infection.
Methods
We describe clinical, biochemical, and imaging features of 4 patients with SAT related to SARS-CoV-2 infection.
Results
All patients were female (age, 29-46 years). SAT developed 16 to 36 days after the resolution of coronavirus disease 2019 (COVID-19). Neck pain radiated to the jaw and palpitations were the main presenting symptoms and were associated with fever and asthenia. One patient was hospitalized because of atrial fibrillation. Thyroid function tests (available for 3 individuals) were suggestive of destructive thyroiditis, and inflammatory markers were high. At neck ultrasound the thyroid was enlarged, with diffuse and bilateral hypoechoic areas and (in 3 patients) absent vascularization at color Doppler. Symptoms disappeared a few days after commencement of treatment (prednisone in 3 patients and ibuprofen in 1). Six weeks after the onset of SAT, all patients were asymptomatic and inflammatory markers had returned to normal range. Two patients were euthyroid, whereas 2 were diagnosed with subclinical hypothyroidism.
Conclusions
SAT may be an underestimated manifestation of COVID-19. Clinicians should keep in mind the possible occurrence of SAT during and after SARS-CoV-2 infection.
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference14 articles.
1. Subacute Thyroiditis after Sars-COV-2 infection;Brancatella;J Clin Endocrinol Metab,2020
2. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. [Published online ahead of print June 2, 2020.];Ippolito;J Endocrinol Invest.
3. A case of subacute thyroiditis associated with Covid-19 infection;Asfuroglu Kalkan;J Endocrinol Invest.,2020
4. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. [Published online ahead of print July 16, 2020.];Ruggeri;Hormones (Athens).
5. Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope;Latrofa;J Endocrinol Invest.,2012
Cited by
132 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献